The association between plasma aldosterone level, transtubular potassium gradient, or their ratios and causes of hyperkalemia in the outpatient setting
| dc.contributor.author | Wuthapanich T. | |
| dc.contributor.author | Phakdeekitcharoen P. | |
| dc.contributor.author | Sevamontree C. | |
| dc.contributor.author | Phakdeekitcharoen B. | |
| dc.contributor.correspondence | Wuthapanich T. | |
| dc.contributor.other | Mahidol University | |
| dc.date.accessioned | 2026-06-22T18:15:30Z | |
| dc.date.available | 2026-06-22T18:15:30Z | |
| dc.date.issued | 2026-03-01 | |
| dc.description.abstract | Background: Hyperkalemia is a lethal condition resulting in cardiac dysrhythmias and death. Identifying the causes of hyperkalemia is crucial for treating and preventing future recurrence. Methods: A prospective cohort study was conducted to evaluate the association between plasma aldosterone level, transtubular potassium gradient, and their ratios in distinguishing the causes of hyperkalemia (serum potassium ≥ 5.8 mmol/L) in the outpatient clinic. Results: Forty-two patients and 26 controls completed the study. The causes of hyperkalemia were classified into three major groups: 1) drug-induced (27 cases), 2) diabetes-related (7 cases), and 3) chronic kidney disease (CKD)-related hyperkalemia (7 cases), and one case of renal tubular acidosis. The mean serum potassium level of the hyperkalemia group was significantly higher than the control group (6.13 ± 0.29 vs 4.27 ± 0.44 mmol/L, P < .001). The mean transtubular potassium gradient values were 3.48 ± 1.87 vs 5.27 ± 1.46, P < .001, respectively. The cut-off aldosterone/transtubular potassium gradient ratio of >2.5 ng/dL or transtubular potassium gradient <5 had comparable sensitivity (64.3% vs 76.2%) and specificity (76.9% vs 53.8%) in discriminating between the hyperkalemia group and the control group, suggesting an inadequate collecting tubule response to hyperkalemia. CKD-related hyperkalemia showed a wide range of transtubular potassium gradients. Lastly, our population was likely to develop diabetes-related hyperkalemia, possibly due to aldosterone resistance from tubular defects. Conclusion: The combined utilization of plasma aldosterone level, transtubular potassium gradient, and their ratios provides a maximum advantage in differentiating causes of hyperkalemia. Additional studies with larger sample sizes and different cut-off serum potassium levels for hyperkalemia are required to further characterize these findings. | |
| dc.identifier.citation | Journal of Nephrology Vol.39 No.2 (2026) , 307-317 | |
| dc.identifier.doi | 10.1093/joneph/aajaf041 | |
| dc.identifier.eissn | 17246059 | |
| dc.identifier.issn | 11218428 | |
| dc.identifier.pmid | 42008517 | |
| dc.identifier.scopus | 2-s2.0-105042123583 | |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/117477 | |
| dc.rights.holder | SCOPUS | |
| dc.subject | Medicine | |
| dc.title | The association between plasma aldosterone level, transtubular potassium gradient, or their ratios and causes of hyperkalemia in the outpatient setting | |
| dc.type | Article | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105042123583&origin=inward | |
| oaire.citation.endPage | 317 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | 307 | |
| oaire.citation.title | Journal of Nephrology | |
| oaire.citation.volume | 39 | |
| oairecerif.author.affiliation | Freeman Hospital | |
| oairecerif.author.affiliation | Faculty of Medicine Ramathibodi Hospital, Mahidol University |
